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PURPOSE: In 1980, operative mortality for esophageal resection was 29%. Over the last 15 years, technical and
critical care improvements contributed to the reduction of postoperative mortality rate to 8%. The aim of this study is to
analyze retrospectively the role of different factors (surgical procedure, stage of the disease, and anesthetic risk) on the
postoperative mortality of 63 patients that underwent esophagectomy with gastric interposition for cancer.
METHODS: Seventy-two patients underwent esophagectomy. The stomach was the esophageal substitute in 63 cases.
Surgical procedures included transthoracic esophagectomy in 49 patients and transhiatal esophagectomy in 14 cases.
Among the 49 transthoracic esophagectomy patients, there were 18 patients with a high anesthetic risk (ASA III). Among the
patients that underwent transhiatal esophagectomy, there were 10 patients with a high anesthetic risk (ASA III).
RESULTS: The operative mortality rate was 14% (2/14) in transhiatal esophagectomy group and 22% (11/49) in
transthoracic esophagectomy group (P = ns). The postoperative mortality of patients with a high anesthetic risk (ASA III)
was 47% (8/17) after transthoracic esophagectomy and 10% (1/10) after transhiatal esophagectomy (P <0.05).
DISCUSSION: In our experience, the operative mortality was nearly 18% (16.6% after transhiatal esophagectomy and
20.8% after transthoracic esophagectomy). Among the patients with a high anesthetic risk (ASA III) that underwent surgery,
the postoperative mortality was significantly lower after transhiatal esophagectomy (10%) compared to transthoracic
esophagectomy (47%) (P <0.05).
DESCRIPTORS: Esophageal carcinoma. Transhiatal esophagectomy. Transthoracic esophagectomy.  Prognostic
factors.  Anesthetic risk.
INTRODUCTION
Esophageal carcinoma has a dismal
prognosis. The 5-year survival rate of
patients with esophageal carcinoma
who underwent surgery has been re-
ported to be only 20%1-3. In a 1980 re-
view article by Earlam and Cunha-
Melo, more than 32,000 esophageal
resections had a collective operative
mortality of 29%4. Over the past 15
years, technical and critical care im-
provements have contributed to the re-
duction of reported postoperative mor-
tality rates from 29%4 to 4%-12%2,5-13.
The aim of this study is to analyze ret-
rospectively the role of different fac-
tors (surgical procedure, stage of the
disease, and anesthetic risk) on the
postoperative mortality, and the mor-
bidity of 63 patients who underwent
esophagectomy with gastric interposi-
tion for cancer from 1978 to 2000.
MATERIALS  AND  METHODS
Between 1978 and 2000, 95 pa-
tients with esophageal carcinoma were
admitted to our Institute. Among them,
72 patients (58 men, mean age 65.5
years; 14 women, mean age 62.5 years)
underwent esophagectomy (resection
rate, 76%). Patients who had jejunum
(7 patients) or colon (2 patients) inter-
position were excluded. Stomach was
the esophageal substitute in 63 cases.
Surgical procedures included tran-
sthoracic esophagectomy (TTE) ac-
cording to Lewis14 in 49 patients and
transhiatal esophagectomy (THE) ac-
cording to Orringer15,16 and Akiyama17-
21 in 14 cases.
The 49 patients that underwent TTE
had spinocellular carcinoma in 42 cases
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and adenocarcinoma in 7 cases. Tumor lo-
cations were cervical esophagus 4% (2 pa-
tients), upper thoracic esophagus 4% (2
patients), midthoracic esophagus 31% (15
patients), and inferior thoracic esophagus
61% (30 patients). TTE patients had an
extensive 2-field en bloc lymphadenec-
tomy. Cervical lymphadenectomy was
performed only for cervical and upper
thoracic esophageal tumors.
Tumor stages were stage I (N0) in
2 patients, stage IIA (N0) in 16 pa-
tients, stage IIB (N1) in 6 patients, and
stage III (N1) in 25 patients. Thirty-one
patients had lymph nodal metastases.
Among the 49 TTE patients, there
were 18 patients (37%) with a high
anesthetic risk (ASA ³ III)22.
Of the 14 patients that underwent
THE, 13 had a spinocellular carcinoma
and 1 had an adenocarcinoma. Tumor
locations were cervical esophagus in
43% (6 cases), upper thoracic esophagus
7% (1 patient), middle thoracic
esophagus 21% (3 cases), and inferior
thoracic esophagus 29% (4 patients).
Lymph node dissection of the lower me-
diastinum and of the abdomen, includ-
ing the region of the left gastric and
celiac arteries, was performed during
THE. Cervical lymph node dissection
was performed for the cervical and up-
per thoracic tumors. Tumor stages were
stage I (N0) in 2 patients, stage IIA (N0)
in 3 patients, stage IIB (N1) in 3 patients,
and stage III (N1) in 6 patients. Nine pa-
tients had lymph nodal metastases. The
organ used for the substitution of the
esophagus was the Akiyama gastric tube
in all the cases. Among the patients that
underwent THE, there were 10 patients
with a high anesthetic risk (ASA ³ III).
Concerning technique, we per-
formed all the cervical anastomoses for
the THE procedures and 30/49 of the
intrathoracic anastomoses for the TTE
procedures using 1 seromuscular inter-
rupted suture of propylene 3/0; we
used the EEA stapler in the other 19
cases of TTE.
Discrete data were compared using
the Chi square test and the Fisher ex-
act test. Continuous data were com-
pared using the Student’s t test. The
log-rank test of Mantel was used to
compare survival curves23.
RESULTS
The 30-day operative mortality
rates were 16.6% (2/14) for THE and
20.8% (11/49) for TTE (P = ns). Vari-
ables related to age, gender, and
histotype are listed in table 1.
Postoperative morbidity (broncho-
pneumonitis, pleural effusion, anasto-
motic leakage, recurrent laryngeal
nerve paralysis, and chylothorax) was
54% (25/49) for TTE and 57% (8/14)
for THE (P = ns). The transhiatal ap-
proach appeared to have a higher in-
cidence of recurrent laryngeal nerve
injuries (33%) (P ≤.01).
Major complications were 8 partial
or total anastomotic leaks (2 after THE
and 6 after TTE, P = ns), 25 respiratory
complications (6 after THE and 19 af-
ter TTE, P = ns), 1 chylothorax after
TTE, and 4 recurrent laryngeal nerve
paralysis after THE (P £0.01) (Table 2).
The postoperative period of hospi-
talization was 24 days (+-6.45 SD) for
the THE patients and 31. 39 days (+-
9.3 SD) for the TTE patients (P <0.05).
The incidence of anastomotic leak-
age was 14% (2/14) after THE and
12% (6/49) after TTE (P = ns). The
mortality for anastomotic leakage af-
ter THE was 50% (1/2), and 80% (5/6)
after TTE (P <0.05). The survival rate
for cases with cervical fistula after
THE (50%) was higher than the sur-
vival rate for cases of intrathoracic fis-
tula after TTE (20%) (P <0.05).
Among the TTE-treated patients,
the incidence of anastomotic leakage
was 10%  (3/30) after manual suture
and 16% (3/19) after mechanical su-
ture. (P = ns). The incidence of anas-
tomotic leakage after manual suture
was 14% (2/14) for the THE group,
and 10% (3/30) after manual suture for
the TTE group (P = ns).
The postoperative mortality of pa-
tients with a high anesthetic risk (ASA
≥ III) was 44% (8/17) after TTE and
10% (1/10) after THE (P <0.05).
Five-year survival rates were 17%
for TTE and 8% for THE (P = ns), and
28.5% of N0 patients and 6% of N+ pa-
tients (P <0.025). The 5-year survival
curves of the patients in relationship
to the presence or the absence of
lymph nodal metastases have been
previously reported24.
DISCUSSION
Over the past few years, technical
and critical care improvements have re-
duced the reported postoperative mor-
tality rate for patients undergoing resec-
Table 1 - Age, gender, and histotype of patients that underwent TTE or THE.
TTE THE P value
Age 63 61 n.s.
Gender 40 males/9 females 11 males/3 females n.s.
Histotype (squamous/ 42/7 13/1 n.s.
adenoK)
Table 2 - Mayor complications: anastomotic leak, respiratory complications,
chylothorax, recurrent laryngeal nerve paralysis.
TTE THE P value
Anastomotic leakage 6/49 2/14 n.s.
Respiratory complications 19/49 6/14 n.s.
Chylothorax 1/49 0/14 n.s.
Recurrent laryngeal nerve injuries 0/49 4/14 P <0.05
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tion of esophageal cancer from 29%4 to
4%-12%2,5-13, and the 5-year survival
rate has improved from 3%-5%4 to
20%1,2,3. In our experience, the 30-day
operative mortality was nearly 18%
(16.6% after THE and 20.8% after
TTE), and there was not a statistically
significant difference between the two
procedures. An extensive review of the
literature revealed that other authors2
report a 30-day mortality of 6.3% for
THE and 9.5% for TTE; TTE had the
higher postoperative mortality rate.
Among the patients with a high
anesthetic risk (ASA ³ III) that underwent
surgery, the postoperative mortality was
significantly lower after THE than after
TTE. It should be noted that THE repre-
sents the best surgical option for patients
with esophageal carcinoma and high
anesthetic risk because it is associated
with reduced surgical trauma, incidence
of respiratory distress, and length of post-
operative stay in hospital. Other authors
report similar results2,3,12.
The postoperative morbidity was
very similar for the 2 surgical proce-
dures. The transhiatal approach ap-
peared to have a higher incidence of
recurrent laryngeal nerve injuries. The
incidence of anastomotic leakage is
slightly higher in the THE group, but
the survival in case of cervical fistula
after THE was better than the survival
in the case of intrathoracic fistula af-
ter TTE. The worst prognosis concern-
ing intrathoracic fistula is probably
secondary to the mediastinitis follow-
ing the anastomotic leakage after TTE.
In these cases, mediastinal drainage
can be introduced after mediastinos-
copy. Anastomotic leaks that occur af-
ter THE tend to have a more benign
course because infection and fistula
can be more easily managed.
There was not a difference in the
incidence of anastomotic leakage af-
ter manual or mechanical anastomoses
for TTE.
The 5-year survival rates were signifi-
cantly higher in patients without lymph
nodal metastases. In a retrospective study,
Japanese authors25,26 reported a better 5-
year survival after extensive collo-
thoraco-abdominal (3-field) dissection, in
particular for stage 0 and stage IV carci-
noma of the upper third of the thoracic
esophagus26. Conversely, in patients with
carcinoma of the lower third of the
esophagus with abdominal lymph nodal
metastases, 3-field dissection was not as-
sociated with improved 5-year survival
rates27. In western countries, surgeons pre-
fer to use preoperative radio- or chemo-
therapy because they consider
esophageal carcinoma to be a dissemi-
nated disease28. Prospective studies12,13
did not demonstrate a significant differ-
ence in the survival rates of patients
treated by TTE with systematic 2-field en
bloc lymphadenectomy or of those
treated by THE.  These results stress the
importance of a diagnosis of the
esophageal cancer and the relative neces-
sity of an extended lymph node dissec-
tion; it follows that patients with a low
anesthetic risk (ASA < III) must be treated
by TTE or by THE, and may eventually
be treated with video-assisted thoracic
lymph node dissection or with mediasti-
noscopy29. In the past few years, treatment
of esophageal carcinoma by video-as-
sisted thoracoscopy (VATS) alone did not
seem to be possible because of the length
of the operation time (10 hours)30. How-
ever, in a recent study31, minimally inva-
sive esophagectomy had a shorter opera-
tive time and less blood loss than THE
and TTE.
We suggest that: i) THE represents
the best surgical option in patients
with a high anesthetic risk (ASA ³ III)
because it reduces postoperative mor-
tality significantly; ii) the long-term
results are significantly correlated with
the presence or the absence of lymph
nodal metastases. Enlarged mediastinal
lymphadenectomy allows the staging
of the disease exactly, but we do not
find that the more radical procedure
(TTE) results in longer survival.
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OBJETIVO: Nos últimos 15 anos,
melhorias técnicas contribuíram para a
redução da taxa de mortalidade pós-
operatória de 29 para 8 %. O objetivo
deste estudo é analisar retrospectiva-
mente o papel de diferentes fatores na
mortalidade pós-operatória de 63 paci-
entes submetidos a esofagectomia para
tratamento de câncer.
MÉTODOS: Sessenta e três paci-
entes foram submetidos a esofagec-
tomia com utilização do estômago
como substituto. Os procedimentos ci-
rúrgicos incluíram esofagectomia
transtorácica em 49 pacientes e esofa-
gectomia trans-hiatal em 14 casos. En-
tre os 49 pacientes de esofagectomia
transtorácica haviam 18 (37%) com
risco anestésico elevado (ASA ≥ III).
Quatorze pacientes foram submetidos
a esofagectomia trans-hiatal.
RESULTADOS: A mortalidade
operatória foi de 14% na esofagectomia
trans-hiatal e 22% na esofagectomia
transtorácica (p = ns). A mortalidade
dos pacientes com risco anestésico
elevado foi de 47 % após esofagec-
tomia transtorácica e 10% após esofa-
gectomia trans-hiatal (p < 0,05).
DISCUSSÃO: Em nossa experiên-
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cia, a mortalidade foi de quase 18% e
22% após esofagectomia transtorácica.
Entre os pacientes com risco anestési-
co elevado que se submeteram à ope-
ração, a mortalidade pós-operatória foi
significativamente mais baixa após a
esofagectomia trans-hiatal (10%) com-
parativamente à esofagectomia trans-
torácica (47 %) (p< 0,05).
DESCRITORES:  Carcinoma de
esôfago.  Esofagectomia trans-hiatal.
Esofagectomia transtorácica.  Fato-
res prognósticos. Risco anestésico.
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